Want to see PACB full AI Analyst Report?
ETFs with Pacific Biosciences (PACB) Exposure
The following ETFs maintain exposure to Pacific Biosciences (PACB). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
53 ETFs Hold Pacific Biosciences (PACB)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in PACB |
|---|---|---|---|---|---|---|
| LOPX | ― | ― | ― | 2.37% | $15.37K | <0.01% |
| ARKG | Ark Genomic Revolution Ucits ETF AccumUSD | $123.47M | 0.79% | 1.55% | $2.15M | 0.24% |
| ARKG | ― | ― | ― | 1.54% | $87.00K | 0.02% |
| ARKG | ARK Genomic Revolution ETF | $2.37B | 0.75% | 1.39% | $30.68M | 3.79% |
| NIFE | ― | ― | ― | 1.27% | $28.75K | <0.01% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | $21.73M | 0.20% | 1.08% | $226.40K | 0.03% |
| ARKK | ARK Innovation UCITS ETF Accum Shs USD | $283.80M | 0.78% | 1.07% | $3.38M | 0.37% |
| EDOC | Global X Telemedicine & Digital Health UCITS ETF Accum Shs USD | $5.82M | 0.68% | 0.85% | $53.30K | <0.01% |
| CSYJ | ― | ― | ― | 0.79% | $45.63K | <0.01% |
| GNMX | Corgi Genomics & Precision Medicine ETF | $1.38M | 0.35% | 0.78% | $10.80K | <0.01% |
| XDNA | iShares Genomics Immunology and Healthcare Index ETF Trust Units | $21.79M | 0.52% | 0.71% | $153.82K | 0.01% |
| IDNA | iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | $337.92M | 0.47% | 0.64% | $2.16M | 0.27% |
| ARKK | ARK Innovation ETF | $6.51B | 0.75% | 0.58% | $35.78M | 4.42% |
| GNOM | Global X Genomics & Biotechnology ETF | $117.53M | 0.50% | 0.54% | $621.39K | 0.07% |
| GN0M | Global X Genomics & Biotechnology UCITS ETF | $155.04M | 0.50% | 0.54% | $835.50K | 0.09% |
| ARKK | ― | ― | ― | 0.54% | $192.00K | 0.04% |
| ZGEN | ― | ― | ― | 0.32% | $9,510.33 | <0.01% |
| SGRW | Harbor Active Small Cap Growth ETF | $28.11M | 0.80% | 0.17% | $48.52K | <0.01% |
| MEDX | Horizon Kinetics Medical ETF | $17.76M | 0.85% | 0.15% | $26.39K | <0.01% |
| ZINN | ― | ― | ― | 0.12% | $11.60K | <0.01% |
| PRFZ | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | 0.10% | $2.54M | 0.31% |
| TNXT | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | 0.08% | $15.11K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.06% | $780.57K | 0.09% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.05% | $62.17K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.05% | $5.92M | 0.73% |
| IWO | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | 0.05% | $6.73M | 0.83% |
| VTWG | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | 0.04% | $684.34K | 0.09% |
| RESM | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | 0.04% | $2,421.5 | <0.01% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | 0.03% | $21.46M | 2.38% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | 0.03% | $89.47K | <0.01% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | 0.03% | $408.14K | 0.05% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | 0.03% | $47.53K | <0.01% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | 0.03% | $1.27M | 0.14% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.02% | $3,455.46 | <0.01% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | 0.02% | $278.4 | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.02% | $4.00M | 0.54% |
| SCHA | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | 0.02% | $4.84M | 0.54% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $8.11M | 1.10% |
| VHT | Vanguard Health Care ETF | $20.70B | 0.09% | <0.01% | $1.82M | 0.25% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $1,023.7 | <0.01% |
| IWN | iShares Russell 2000 Value ETF | $14.23B | 0.24% | <0.01% | $600.37K | 0.07% |
| DFMC | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | <0.01% | $264.66K | 0.06% |
| VTWV | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | <0.01% | $42.62K | <0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | <0.01% | $1.25M | 0.14% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $25.76K | <0.01% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $515.69K | 0.06% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $204.03K | 0.02% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $22.60M | 3.07% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $54.05K | <0.01% |
| DFAS | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | <0.01% | $30.33K | <0.01% |
| DFAC | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | <0.01% | $48.86K | <0.01% |
| DFUS | Dimensional U.S. Equity ETF | $21.88B | 0.09% | <0.01% | $8,665.2 | <0.01% |
| DCOR | Dimensional US Core Equity 1 ETF | $3.70B | 0.14% | <0.01% | $1,307.9 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in PACB |
|---|---|---|---|---|---|---|
| LOPX | 2.37% | ― | ― | ― | $15.37K | <0.01% |
| ARKG | 1.55% | Ark Genomic Revolution Ucits ETF AccumUSD | $123.47M | 0.79% | $2.15M | 0.24% |
| ARKG | 1.54% | ― | ― | ― | $87.00K | 0.02% |
| ARKG | 1.39% | ARK Genomic Revolution ETF | $2.37B | 0.75% | $30.68M | 3.79% |
| NIFE | 1.27% | ― | ― | ― | $28.75K | <0.01% |
| QQQS | 1.08% | Invesco NASDAQ Future Gen 200 ETF | $21.73M | 0.20% | $226.40K | 0.03% |
| ARKK | 1.07% | ARK Innovation UCITS ETF Accum Shs USD | $283.80M | 0.78% | $3.38M | 0.37% |
| EDOC | 0.85% | Global X Telemedicine & Digital Health UCITS ETF Accum Shs USD | $5.82M | 0.68% | $53.30K | <0.01% |
| CSYJ | 0.79% | ― | ― | ― | $45.63K | <0.01% |
| GNMX | 0.78% | Corgi Genomics & Precision Medicine ETF | $1.38M | 0.35% | $10.80K | <0.01% |
| XDNA | 0.71% | iShares Genomics Immunology and Healthcare Index ETF Trust Units | $21.79M | 0.52% | $153.82K | 0.01% |
| IDNA | 0.64% | iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | $337.92M | 0.47% | $2.16M | 0.27% |
| ARKK | 0.58% | ARK Innovation ETF | $6.51B | 0.75% | $35.78M | 4.42% |
| GNOM | 0.54% | Global X Genomics & Biotechnology ETF | $117.53M | 0.50% | $621.39K | 0.07% |
| GN0M | 0.54% | Global X Genomics & Biotechnology UCITS ETF | $155.04M | 0.50% | $835.50K | 0.09% |
| ARKK | 0.54% | ― | ― | ― | $192.00K | 0.04% |
| ZGEN | 0.32% | ― | ― | ― | $9,510.33 | <0.01% |
| SGRW | 0.17% | Harbor Active Small Cap Growth ETF | $28.11M | 0.80% | $48.52K | <0.01% |
| MEDX | 0.15% | Horizon Kinetics Medical ETF | $17.76M | 0.85% | $26.39K | <0.01% |
| ZINN | 0.12% | ― | ― | ― | $11.60K | <0.01% |
| PRFZ | 0.10% | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | $2.54M | 0.31% |
| TNXT | 0.08% | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | $15.11K | <0.01% |
| OM3E | 0.06% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $780.57K | 0.09% |
| IBBQ | 0.05% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $62.17K | <0.01% |
| IBB | 0.05% | iShares Biotechnology ETF | $11.52B | 0.44% | $5.92M | 0.73% |
| IWO | 0.05% | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | $6.73M | 0.83% |
| VTWG | 0.04% | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | $684.34K | 0.09% |
| RESM | 0.04% | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | $2,421.5 | <0.01% |
| IWM | 0.03% | iShares Russell 2000 ETF | $76.76B | 0.19% | $21.46M | 2.38% |
| RTYS | 0.03% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $89.47K | <0.01% |
| RSSL | 0.03% | Global X Russell 2000 ETF | $1.47B | 0.08% | $408.14K | 0.05% |
| ITWO | 0.03% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $47.53K | <0.01% |
| R2EH | 0.03% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $1.27M | 0.14% |
| VRSD | 0.02% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $3,455.46 | <0.01% |
| RB | 0.02% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $278.4 | <0.01% |
| VTWO | 0.02% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $4.00M | 0.54% |
| SCHA | 0.02% | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | $4.84M | 0.54% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $8.11M | 1.10% |
| VHT | <0.01% | Vanguard Health Care ETF | $20.70B | 0.09% | $1.82M | 0.25% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $1,023.7 | <0.01% |
| IWN | <0.01% | iShares Russell 2000 Value ETF | $14.23B | 0.24% | $600.37K | 0.07% |
| DFMC | <0.01% | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | $264.66K | 0.06% |
| VTWV | <0.01% | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | $42.62K | <0.01% |
| ITOT | <0.01% | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | $1.25M | 0.14% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $25.76K | <0.01% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $515.69K | 0.06% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $204.03K | 0.02% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $22.60M | 3.07% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $54.05K | <0.01% |
| DFAS | <0.01% | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | $30.33K | <0.01% |
| DFAC | <0.01% | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | $48.86K | <0.01% |
| DFUS | <0.01% | Dimensional U.S. Equity ETF | $21.88B | 0.09% | $8,665.2 | <0.01% |
| DCOR | <0.01% | Dimensional US Core Equity 1 ETF | $3.70B | 0.14% | $1,307.9 | <0.01% |
Popular ETF Comparisons
PACB ETF Exposure FAQ
What ETFs hold Pacific Biosciences stock?
Pacific Biosciences (PACB) is currently held by 53 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to PACB include ARK (ARKG), ARK (IT:ARKK) and ARK (IT:ARKG).
Which ETF has the largest exposure to PACB?
The ETF with the largest exposure to PACB is ARK (ARKG), with approximately $30.68M in market value exposure.
How much PACB stock is held by ETFs?
ETFs currently hold approximately $36.67M worth of Pacific Biosciences (PACB) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.